Invicta Diagnostic IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Dec 01 to Dec 03 2025
Price Band
₹80 - 85
Current GMP
₹100.0 (+17.65%)
Subscription
4.27 times
IPO Details
| IPO Date | Mon, Dec 1, 2025 to Wed, Dec 3, 2025 |
| Listing Date | Mon, Dec 8, 2025 |
| Face Value | ₹ 10 per share |
| Issue Price Band | ₹80 to ₹85 per share |
| Issue Price | ₹85 per share |
| Lot Size | 1,600 Shares |
| Sale Type | Fresh Capital |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Total Issue Size | 33,08,800 shares (aggregating up to ₹ 28.12 Cr) |
| Reserved for Market Maker | 1,66,400 shares (aggregating up to ₹ 1.41 Cr) Nikunj Stock Brokers Ltd. |
| Net Offered to Public | 31,42,400 shares (aggregating up to ₹ 26.71 Cr) |
| Share Holding Pre Issue | 92,63,173 shares |
| Share Holding Post Issue | 1,25,71,973 shares |
| NSE Symbol | INVICTA |
| ISIN | INE0XJ501010 |
IPO Date
Mon, Dec 1, 2025 to Wed, Dec 3, 2025
Listing Date
Mon, Dec 8, 2025
Face Value
₹ 10 per share
Issue Price Band
₹80 to ₹85 per share
Issue Price
₹85 per share
Lot Size
1,600 Shares
Sale Type
Fresh Capital
Issue Type
Bookbuilding IPO
Listing At
NSE SME
Total Issue Size
33,08,800 shares (aggregating up to ₹ 28.12 Cr)
Reserved for Market Maker
1,66,400 shares (aggregating up to ₹ 1.41 Cr) Nikunj Stock Brokers Ltd.
Net Offered to Public
31,42,400 shares (aggregating up to ₹ 26.71 Cr)
Share Holding Pre Issue
92,63,173 shares
Share Holding Post Issue
1,25,71,973 shares
NSE Symbol
INVICTA
ISIN
INE0XJ501010
IPO Subscription Details
| Anchor Investors | 1 |
| Market Maker | 1 |
| QIB (Ex Anchor) | 3.51 |
| Non-Institutional Buyers*** | 6.96 |
| bNII (bids above ₹10L) | 7.30 |
| sNII (bids below ₹10L) | 6.27 |
| Individual Investors (IND category bidding for 2 Lots) | 3.44 |
| Total ** | 4.27 |
Anchor Investors
1
Market Maker
1
QIB (Ex Anchor)
3.51
Non-Institutional Buyers***
6.96
bNII (bids above ₹10L)
7.30
sNII (bids below ₹10L)
6.27
Individual Investors (IND category bidding for 2 Lots)
3.44
Total **
4.27
Day Wise Sub
| Day | QIB (Ex Anchor) | NII* | NII (> ₹10L) | NII (< ₹10L) | Individual Investors | Total |
|---|---|---|---|---|---|---|
| Day 1 Dec 1, 2025 | 1.00 | 0.68 | 0.79 | 0.45 | 0.29 | 0.54 |
| Day 2 Dec 2, 2025 | 1.55 | 0.74 | 0.81 | 0.58 | 0.79 | 0.95 |
| Day 3 Dec 3, 2025 | 3.51 | 6.96 | 7.30 | 6.27 | 3.44 | 4.27 |
DayDay 1
Dec 1, 2025
QIB (Ex Anchor)1.00
NII*0.68
NII (> ₹10L)0.79
NII (< ₹10L)0.45
Individual Investors0.29
Total0.54
DayDay 2
Dec 2, 2025
QIB (Ex Anchor)1.55
NII*0.74
NII (> ₹10L)0.81
NII (< ₹10L)0.58
Individual Investors0.79
Total0.95
DayDay 3
Dec 3, 2025
QIB (Ex Anchor)3.51
NII*6.96
NII (> ₹10L)7.30
NII (< ₹10L)6.27
Individual Investors3.44
Total4.27
Day Wise GMP
| Date | Price | GMP | Estimate List Price |
|---|---|---|---|
| 08-12-2025 | 85.00 | 0(0.00%) | 85 |
| 07-12-2025 | 85.00 | 0(0.00%) | 85 |
| 06-12-2025 | 85.00 | 0(0.00%) | 85 |
| 05-12-2025 | 85.00 | 0(0.00%) | 85 |
| 04-12-2025 | 85.00 | 0(0.00%) | 85 |
| 03-12-2025 | 85.00 | 0(0.00%) | 85 |
| 02-12-2025 | 85.00 | 3(3.53%) | 88 |
| 01-12-2025 | 85.00 | 0(0.00%) | 85 |
| 30-11-2025 | 85.00 | 0(0.00%) | 85 |
| 29-11-2025 | 85.00 | 0(0.00%) | 85 |
| 28-11-2025 | 85.00 | 0(0.00%) | 85 |
| 27-11-2025 | 85.00 | 0(0.00%) | 85 |
| 26-11-2025 | 85.00 | 0(0.00%) | 85 |
| 25-11-2025 | 85.00 | 0(0.00%) | 85 |
Date08-12-2025
Price85.00
GMP0(0.00%)
Estimate List Price85
Date07-12-2025
Price85.00
GMP0(0.00%)
Estimate List Price85
Date06-12-2025
Price85.00
GMP0(0.00%)
Estimate List Price85
Date05-12-2025
Price85.00
GMP0(0.00%)
Estimate List Price85
Date04-12-2025
Price85.00
GMP0(0.00%)
Estimate List Price85
Date03-12-2025
Price85.00
GMP0(0.00%)
Estimate List Price85
Date02-12-2025
Price85.00
GMP3(3.53%)
Estimate List Price88
Date01-12-2025
Price85.00
GMP0(0.00%)
Estimate List Price85
Date30-11-2025
Price85.00
GMP0(0.00%)
Estimate List Price85
Date29-11-2025
Price85.00
GMP0(0.00%)
Estimate List Price85
Date28-11-2025
Price85.00
GMP0(0.00%)
Estimate List Price85
Date27-11-2025
Price85.00
GMP0(0.00%)
Estimate List Price85
Date26-11-2025
Price85.00
GMP0(0.00%)
Estimate List Price85
Date25-11-2025
Price85.00
GMP0(0.00%)
Estimate List Price85
IPO Important Dates
| IPO Open Date | Mon, Dec 1, 2025 |
| IPO Close Date | Wed, Dec 3, 2025 |
| Tentative Allotment | Thu, Dec 4, 2025 |
| Initiation of Refunds | Fri, Dec 5, 2025 |
| Credit of Shares to Demat | Fri, Dec 5, 2025 |
| Tentative Listing Date | Mon, Dec 8, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on Wed, Dec 3, 2025 |
IPO Open Date
Mon, Dec 1, 2025
IPO Close Date
Wed, Dec 3, 2025
Tentative Allotment
Thu, Dec 4, 2025
Initiation of Refunds
Fri, Dec 5, 2025
Credit of Shares to Demat
Fri, Dec 5, 2025
Tentative Listing Date
Mon, Dec 8, 2025
Cut-off time for UPI mandate confirmation
5 PM on Wed, Dec 3, 2025
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 3,200 | ₹2,72,000 |
| Individual investors (Retail) (Max) | 2 | 3,200 | ₹2,72,000 |
| S-HNI (Min) | 3 | 4,800 | ₹4,08,000 |
| S-HNI (Max) | 7 | 11,200 | ₹9,52,000 |
| B-HNI (Min) | 8 | 12,800 | ₹10,88,000 |
ApplicationIndividual investors (Retail) (Min)
Lots2
Shares3,200
Amount₹2,72,000
ApplicationIndividual investors (Retail) (Max)
Lots2
Shares3,200
Amount₹2,72,000
ApplicationS-HNI (Min)
Lots3
Shares4,800
Amount₹4,08,000
ApplicationS-HNI (Max)
Lots7
Shares11,200
Amount₹9,52,000
ApplicationB-HNI (Min)
Lots8
Shares12,800
Amount₹10,88,000
Financial Information
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 34.90 | 21.22 | 15.89 |
| Total Income | 17.08 | 30.18 | 15.90 |
| Profit After Tax | 4.08 | 4.93 | 3.81 |
| EBITDA | 6.77 | 9.20 | 7.09 |
| NET Worth | 23.68 | 13.60 | 8.67 |
| Reserves and Surplus | 14.42 | 5.18 | 8.54 |
| Total Borrowing | 3.72 | 3.54 | 3.81 |
Period EndedAssets
30 Sep 202534.90
31 Mar 202521.22
31 Mar 202415.89
Period EndedTotal Income
30 Sep 202517.08
31 Mar 202530.18
31 Mar 202415.90
Period EndedProfit After Tax
30 Sep 20254.08
31 Mar 20254.93
31 Mar 20243.81
Period EndedEBITDA
30 Sep 20256.77
31 Mar 20259.20
31 Mar 20247.09
Period EndedNET Worth
30 Sep 202523.68
31 Mar 202513.60
31 Mar 20248.67
Period EndedReserves and Surplus
30 Sep 202514.42
31 Mar 20255.18
31 Mar 20248.54
Period EndedTotal Borrowing
30 Sep 20253.72
31 Mar 20253.54
31 Mar 20243.81
Key Performance Indicator
| ROE | 44.28% |
| ROCE | 42.00% |
| Debt/Equity | 0.26 |
| RoNW | 36.25% |
| PAT Margin | 16.38% |
| EBITDA Margin | 30.57% |
| Price to Book Value | 5.26 |
ROE
44.28%
ROCE
42.00%
Debt/Equity
0.26
RoNW
36.25%
PAT Margin
16.38%
EBITDA Margin
30.57%
Price to Book Value
5.26
IPO Reservation
| Market Maker Shares Offered | 1,66,400 (5.03%) |
| QIB Shares Offered | 13,32,800 (40.28%) |
| − Anchor Investor Shares Offered | 7,98,400 (24.13%) |
| − QIB (Ex. Anchor) Shares Offered | 5,34,400 (16.15%) |
| NII (HNI) Shares Offered | 5,42,400 (16.39%) |
| − bNII > ₹10L | 3,61,600 (10.93%) |
| − sNII < ₹10L | 1,80,800 (5.46%) |
| Retail Shares Offered | 12,67,200 (38.30%) |
| Total Shares Offered | 33,08,800 (100.00%) |
Market Maker Shares Offered
1,66,400 (5.03%)
QIB Shares Offered
13,32,800 (40.28%)
− Anchor Investor Shares Offered
7,98,400 (24.13%)
− QIB (Ex. Anchor) Shares Offered
5,34,400 (16.15%)
NII (HNI) Shares Offered
5,42,400 (16.39%)
− bNII > ₹10L
3,61,600 (10.93%)
− sNII < ₹10L
1,80,800 (5.46%)
Retail Shares Offered
12,67,200 (38.30%)
Total Shares Offered
33,08,800 (100.00%)
Objectives of IPO
The Company Invicta Diagnostic IPO proposes to utilise the Net Proceeds from the Issue towards the following objects: S.No. Objects of the Issue Expected Amount (₹ in crores) 1 Funding capital expenditure for purchase of medical equipment towards establishment of five new diagnostic centres in Maharashtra; and 21.11 2 General Corporate purposes 4.07
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App